Skip to main content

Table 3 The mean tumour necrosis factor α (TNF-α), nuclear factor kappa β (NFK-β), and interleukin 6 (IL-6) expressions according to experimental groups

From: Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?

 

TNF-α (expressions relative to β-actin)

NFK-β (expressions relative to β-actin)

IL-6 (expressions relative to β-actin)

Groups

Mean

Standard deviation

Mean

Standard deviation

Mean

Standard deviation

Healthy (I)

2.150

0.105

2.417

0.147

3.300

0.179

GLY (II)

9.317

0.232

11.333

0.216

13.250

0.188

CM (III)

2.300

0.141

2.450

0.164

3.200

0.110

GLY+CM (IV)

20.350

0.207

25.367

0.207

30.183

0.117

CM+LEVO 0.25 (V)

2.633

0.137

2.517

0.075

3.300

0.141

GLY+CM+LEVO 0.25 (VI)

7.167

0.103

8.167

0.103

10.333

0.216

CM+LEVO 0.5 (VII)

2.517

0.147

2.683

0.147

3.350

0.187

GLY+CM+LEVO 0.5 (VIII)

5.367

0.163

5.183

0.117

5.250

0.187

  1. CM Contrast medium, GLY Glycerol, IL-6 Interleukin 6, LEVO Levosimendan, NFK-ß Nuclear factor kappa ß, TNF-α Tumour necrosis factor α